Macromoltek’s Computational De Novo Antibody Design to Target Covid-19
Computational (in silico) design allows for rapid iteration around potential solutions without the unique variables that traditional in vivo subjects may possess.
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Computational (in silico) design allows for rapid iteration around potential solutions without the unique variables that traditional in vivo subjects may possess.
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Test results can be obtained within 15 minutes from a simple fingerstick, utilizing Chembio’s MicroReader 1 and MicroReader 2 analyzers.
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Dozens of laboratories in Africa, Asia, Europe, Latin America, and the Caribbean will receive diagnostic machines and kits, reagents, and laboratory consumables
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
PCR Biosystems has significantly increased manufacture of its qPCRBIO Probe 1-Step Go and all other critical reagents for rapid and sensitive RT-qPCR.
Read MorePosted by | Apr 8, 2020 | Biochemicals & Chemical Reagents, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
In response to the covid-19 pandemic, FDA has developed quality-controlled reference sequence data for the SARS-CoV-2 reference strain for the United States.
Read More